Previous Article | Next Article 
Journal of Clinical Microbiology, September 2001, p. 3417-3419, Vol. 39, No. 9
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.9.3417-3419.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Native Valve Endocarditis Due to Bartonella
henselae in a Middle-Aged Human Immunodeficiency
Virus-Negative Woman
Guy R.
De La Rosa,1
Ben J.
Barnett,1,*
Charles
D.
Ericsson,1 and
Jeffrey
B.
Turk2
Departments of Infectious
Diseases1 and Internal
Medicine,2 The University of Texas Medical
School, Houston, Texas
Received 28 November 2000/Returned for modification 23 April
2001/Accepted 7 July 2001
 |
ABSTRACT |
We report the case of a human immunodeficiency virus-negative woman
who developed native valve endocarditis of the aortic valve due to
Bartonell henselae infection. The diagnosis was established using serology and PCR analysis of excised aortic valve tissue.
 |
CASE REPORT |
A 38-year-old woman having a remote
history of intravenous drug use was admitted to Lyndon B. Johnson
Hospital in May 2000 after she presented to the emergency room. She
complained of fever, nausea, vomiting, and nonbloody diarrhea over a
2-week period associated with fatigue and generalized weakness. She
lived in Texas and owned a fully grown cat and two kittens. Initial
examination of the patient revealed a temperature of 39°C, a grade
3/6 diastolic murmur, and splenomegaly. Laboratory evaluation showed
the following values: white blood cell count, 2.4 × 109/liter; hemoglobin level, 11.9 g/dl; platelet count,
62 × 109/liter. In addition, a chest radiograph
showed moderate cardiomegaly but no effusions or infiltrates. Because
of a high level of suspicion that the patient had infective
endocarditis, transthoracic echocardiography was performed on the day
of admission, which demonstrated the presence of a large, mobile
vegetation on a bicuspid aortic valve.
Initially, the patient received empirical treatment for infective
endocarditis with a combination of vancomycin and gentamicin. Twenty-four hours later, a transesophageal echo test was performed, revealing a 2-cm vegetation attached to both cusps of the bicuspid aortic valve, moderate aortic regurgitation, dilatation of the ascending aorta without evidence of abscess formation, and concentric left ventricular hypertrophy. Two weeks after that, a total of six sets
of blood cultures collected by adult isolator tubes prior to and after
initiation of antibiotic treatment yielded no growth. Additionally,
serum specimens were collected for infectious serology, including
agents of culture-negative endocarditis. Subsequently, the patient's
hospital course was complicated by the development of
glomerulonephritis secondary to her infective endocarditis and
nonoliguric acute renal failure due to aminoglycoside toxicity. The
serum creatinine level peaked at 3.5 mg/dl. Bartonella
serology using an indirect immunofluorescence assay (IFA; Microbiology Reference Laboratory, Cypress, Calif.) showed the following titers: Bartonella henselae immunoglobulin M (IgM), 1:20 (reference
range, negative, <1:20); B. henselae IgG, 1:512 (reference
range, negative, <1:64); Bartonella quintana IgM, 1:20
(reference range, negative, <1:20); B. quintana IgG,
1:512 (reference range, negative, <1:64). When a serology result
positive for Bartonella species was reported, the patient's
antibiotic regimen was changed to ceftriaxone and azithromycin.
Serological tests for Brucella, Chlamydia, and
Coxiella species, other common etiological agents of
culture-negative endocarditis, were negative.
Because of the patient's persistent febrile episodes and the presence
of no obvious source other than her infective endocarditis, she
underwent aortic valve replacement approximately 8 weeks after being admitted to the hospital. PCR (Microbiology Reference
Laboratory) confirmed the presence of B. henselae
in the vegetation.
Stained sections of the patient's aortic valve cusps with hematoxylin
and eosin showed nonvascularization, focal necrosis, and infiltration
by a predominance of chronic inflammatory cells, as well as
neutrophils. Also, Gram and Grocott-Gomori methenamine silver staining
showed that no microorganisms were present in valvular tissues. Culture
analyses of the vegetation and cardiac valvular tissue samples by
recommended techniques (18) were negative for
Bartonella species after 28 days of incubation.
The patient's overall clinical condition improved soon after the valve
replacement. She became afebrile, and her serum creatinine level
gradually decreased over a period of 2 weeks to 1.2 mg/dl. During the
second postoperative week, she developed a postpericardiotomy syndrome-related pericardial effusion that was managed medically and
did not require invasive intervention. The patient was then discharged,
and she completed a 6-week course of oral azithromycin and levofloxacin
at home. Seven months after the surgery, the patient remained
clinically stable.
Culture-negative endocarditis remains a diagnostic and therapeutic
problem, accounting for 5 to 30% of all endocarditis cases (13,
19, 20). Bartonella was first described as a cause of
endocarditis in two separate reports in 1993 (7, 16). More
recently, it has been recognized as an important cause of culture-negative endocarditis (4, 14, 17). Three
Bartonella species, in particular, are known to cause
infective endocarditis: B. henselae, B. quintana, and B. elizabethae. In a multicenter international study that evaluated patients having culture-negative endocarditis (14), 22 patients having
Bartonella endocarditis were found: 5 were infected with
B. quintana, 4 were infected with B. henselae, and 13 were infected with an undetermined
Bartonella species. More recently, Bartonella
vinsonii subsp. berkhoffii was described as the agent
of afebrile culture-negative endocarditis in a 35-year-old male patient
having a bicuspid aortic valve vegetation (15). This
species had previously been isolated only from blood samples obtained
from a healthy dog, as well as a dog suffering from valvular
endocarditis (5, 9).
The epidemiologic features of patients having Bartonella
endocarditis are variable. While almost all reports of
Bartonella endocarditis have involved adults, two recent
cases were reported in pediatric patients (2, 3). Overall,
approximately 85 to 90% of the cases have involved men. The clinical
features of patients having Bartonella endocarditis are
similar to those previously reported in patients having infective
endocarditis (14). Approximately 90% of patients having
Bartonella endocarditis have involvement of the aortic
valve. Finally, in the largest series (14), approximately 50% of the patients had evidence of a preexisting valvular disease, as
did our patient.
Blood cultures from patients with Bartonella endocarditis
require prolonged incubation before they become positive (if they become positive at all), and they are not considered the optimal diagnostic test for this organism. Indeed, in the multicenter international study described above (14), only 5 (23%) of
22 patients had blood cultures positive for Bartonella at
any time during their clinical course. The best method for isolation of the organism is the use of pediatric or adult isolator tubes (Wampole, Cranbury, N.J.) or EDTA blood tubes (18).
Bartonella species also require specific laboratory
conditions for optimal growth, making them difficult to isolate and to
grow. Recovery of Bartonella species from subcultures is
enhanced by plating samples onto heart infusion or chocolate agar
supplemented with 5% rabbit blood (18). The agar plates
should be incubated for at least 21 days in 5% CO2 at 35 to 37°C.
The histopathology of cardiac valvular tissue may contribute to the
etiologic diagnosis of Bartonella endocarditis when serology or molecular techniques are not available. Hematoxylin and eosin staining of the involved valve typically shows inflamed connective tissue with focal granulation. Warthin-Starry silver staining may, in
some instances, reveal the organisms as dark-stained bacteria. In one
study, the cardiac valve pathology of 15 patients having confirmed
Bartonella endocarditis was compared with that in 25 cases
of non-Bartonella endocarditis using computerized
quantitative image analysis (10). In contrast with the
other cases of infective endocarditis, the Bartonella
endocarditis cases were more fibrotic and calcified, were less
vascularized, and had less extensive vegetation and chronic inflammation.
Given the highly fastidious nature of Bartonella species,
clinicians must rely upon other modalities to diagnose infection. IFA
and enzyme-linked immunosorbent assay are the two serologic methods
currently used to diagnose Bartonella infections. It is of
note that our patient had an indirect IFA titer of 1:512 for Bartonella species. On the other hand, in the multicenter
international series (14), all but one patient with
Bartonella endocarditis had titers of
1:1,600 as
determined by microimmunofluorescence. Because most
Bartonella-related infections have been described only
recently and the number of cases is still relatively small, the titer
at which antibody levels become significant for the diagnosis of
infection has yet to be determined. Although clearly defined cutoff
levels for a Bartonella-positive serology test do not exist,
some would consider an IgG titer of >100 to be significant (11). In addition, several groups have questioned the
specificity of antibody estimation tests. Current serologic tests do
not reliably distinguish B. quintana antibody responses
from B. henselae ones. Cross-reactivity between
Bartonella species and other organisms, including
Coxiella burnetii (6) and Chlamydia
species (8), has been reported. Drancourt et al.
(8) reported that patients having B. quintana-induced endocarditis had IgG titers of >256 against
Chlamydia pneumoniae and >64 against Chlamydia
trachomatis and Chlamydia psittaci. However, our
patient had negative serology results for Chlamydia species.
PCR has been a very useful technique for demonstrating
Bartonella DNA in cardiac valvular tissue, especially when
fresh valvular tissue is used (14). In the present case, a
PCR assay using the degenerate primers CAT1 and CAT2, which allow
amplification of a 414-bp fragment of DNA from B. henselae and B. quintana (1), was used. It is of note that PCR can distinguish all of the
Bartonella species.
The optimal antibiotic therapy for Bartonella endocarditis
is unknown. First, the role of antibiotic therapy is limited by the
fact that most Bartonella endocarditis patients have
undergone valve replacement despite intravenous antimicrobial therapy
(8, 14, 17). Second, the literature consists mostly of
series of case reports and does not show use of a consistent antibiotic therapy regimen. Finally, it should be noted that
Bartonella-induced endocarditis usually results in extensive
valve damage, requiring replacement (7, 8). A study
investigating the bactericidal activity of antibiotics against
Bartonella species in vitro found only aminoglycosides to be
bactericidal against B. henselae either in
axenic broths or in cocultivation with eucaryotic cell lines (12). An antibiotic regimen for Bartonella
endocarditis consisting of gentamicin and either ceftriaxone or
doxycycline has been suggested, however (11). Based on
experience with other Bartonella infections, the use of
macrolides (erythromycin, azithromycin, and clarithromycin) is a
reasonable option, but given their static nature, the addition of a
bactericidal agent is recommended.
In summary, we have described a case of native valve endocarditis
caused by B. henselae in a human
immunodeficiency virus-negative woman. The diagnosis was made by using
serology (to the genus level) and PCR analysis of surgical tissue
samples (to the species level). The patient underwent aortic valve
replacement and then received a course of levofloxacin and azithromycin
and continues to do well.
Bartonella infection should be included in the differential
diagnosis of culture-negative endocarditis. Early use of
Bartonella serology (as well as C. burnetii,
Chlamydia, and Brucella serology) is recommended in
those cases in which properly obtained blood cultures do not establish
the etiology of the endocarditis. Nonculture techniques such as
serology and PCR analysis of surgical tissue may be the diagnostic
methods of choice given the difficulty in culturing these organisms.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: The University
of Texas-Houston Medical School, 6431 Fannin St., Room 1.728 JFB,
Houston, TX 77030. Phone: (713) 500-6757. Fax: (713) 500-5495. E-mail: Ben.J.Barnett{at}uth.tmc.edu.
 |
REFERENCES |
| 1.
|
Anderson, B.,
K. Sims,
R. Regnery,
L. Robinson,
M. J. Schmidt,
S. Gorai,
C. Hager, and K. Edwards.
1994.
Detection of Rochalimaea henselae DNA in specimens from cat scratch disease patients by PCR.
J. Clin. Microbiol.
32:942-948[Abstract/Free Full Text].
|
| 2.
|
Baorto, E.,
R. M. Payne,
L. N. Slater,
F. Lopez,
D. A. Relman,
K. W. Min, and J. W. St Geme, 3rd.
1998.
Culture-negative endocarditis caused by Bartonella henselae.
J. Pediatr.
132:1051-1054[CrossRef][Medline].
|
| 3.
|
Barbe, K. P.,
E. Jaeggi,
B. Ninet,
N. Liassine,
C. Donatiello,
A. Gervaix, and S. Suter.
2000.
Bartonella quintana endocarditis in a child.
N. Engl. J. Med.
342:1841-1842[Free Full Text].
|
| 4.
|
Breathnach, A. S.,
J. M. Hoare, and S. J. Eykyn.
1997.
Culture-negative endocarditis: contribution of Bartonella infections.
Heart
77:474-476[Abstract/Free Full Text].
|
| 5.
|
Breitschwerdt, E. B.,
D. L. Kordick,
D. E. Malarkey,
B. Keene,
T. L. Hadfield, and K. Wilson.
1995.
Endocarditis in a dog due to infection with a novel Bartonella subspecies.
J. Clin. Microbiol.
33:154-160[Abstract].
|
| 6.
|
Cooper, M. D.,
M. R. Hollingdale,
J. W. Vinson, and J. Costa.
1976.
A passive hemagglutination test for the diagnosis of trench fever due to Rochalimaea quintana.
J. Infect. Dis.
134:605-609[Medline].
|
| 7.
|
Daly, J. S.,
M. G. Worthington,
D. J. Brenner,
C. W. Moss,
D. G. Hollis,
R. S. Weyant,
A. G. Steigerwalt,
R. E. Weaver,
M. I. Daneshvar, and S. P. O'Connor.
1993.
Rochalimaea elizabethae sp. nov. isolated from a patient with endocarditis.
J. Clin. Microbiol.
31:872-881[Abstract/Free Full Text].
|
| 8.
|
Drancourt, M.,
J. L. Mainardi,
P. Brouqui,
F. Vandenesch,
A. Carta,
F. Lehnert,
J. Etienne,
F. Goldstein,
J. Acar, and D. Raoult.
1995.
Bartonella (Rochalimaea) quintana endocarditis in three homeless men.
N. Engl. J. Med.
332:419-423[Abstract/Free Full Text].
|
| 9.
|
Kordick, D. L.,
B. Swaminathan,
C. E. Greene,
K. H. Wilson,
A. M. Whitney,
S. O'Connor,
D. G. Hollis,
G. M. Matar,
A. G. Steigerwalt,
G. B. Malcolm,
P. S. Hayes,
T. L. Hadfield,
E. B. Breitschwerdt, and D. J. Brenner.
1996.
Bartonella vinsonii subsp. berkhoffii subsp. nov., isolated from dogs; Bartonella vinsonii subsp. vinsonii; and emended description of Bartonella vinsonii.
Int. J. Syst. Bacteriol.
46:704-709[Abstract/Free Full Text].
|
| 10.
|
Lepidi, H.,
P. E. Fournier, and D. Raoult.
2000.
Quantitative analysis of valvular lesions during Bartonella endocarditis.
Am. J. Clin. Pathol.
114:880-889[CrossRef][Medline].
|
| 11.
|
Maurin, M., and D. Raoult.
1996.
Bartonella (Rochalimaea) quintana infections.
Clin. Microbiol. Rev.
9:273-292[Abstract].
|
| 12.
|
Musso, D.,
M. Drancourt, and D. Raoult.
1995.
Lack of bactericidal effect of antibiotics except aminoglycosides on Bartonella (Rochalimaea) henselae.
J. Antimicrob. Chemother.
36:101-108[Abstract/Free Full Text].
|
| 13.
|
Pesanti, E. L., and I. M. Smith.
1979.
Infective endocarditis with negative blood cultures. An analysis of 52 cases.
Am. J. Med.
66:43-50[CrossRef][Medline].
|
| 14.
|
Raoult, D.,
P. E. Fournier,
M. Drancourt,
T. J. Marrie,
J. Etienne,
J. Cosserat,
P. Cacoub,
Y. Poinsignon,
P. Leclercq, and A. M. Sefton.
1996.
Diagnosis of 22 new cases of Bartonella endocarditis.
Ann. Intern. Med.
125:646-652[Abstract/Free Full Text].
|
| 15.
|
Roux, V.,
S. J. Eykyn,
S. Wyllie, and D. Raoult.
2000.
Bartonella vinsonii subsp. berkhoffii as an agent of afebrile blood culture-negative endocarditis in a human.
J. Clin. Microbiol.
38:1698-1700[Abstract/Free Full Text].
|
| 16.
|
Spach, D. H.,
K. P. Callis,
D. S. Paauw,
Y. B. Houze,
F. D. Schoenknecht,
D. F. Welch, and H. Rosen.
1993.
Endocarditis caused by Rochalimaea quintana in a patient infected with human immunodeficiency virus.
J. Clin. Microbiol.
31:692-694[Abstract/Free Full Text].
|
| 17.
|
Spach, D. H.,
A. S. Kanter,
N. A. Daniels,
D. J. Nowowiejski,
A. M. Larson,
R. A. Schmidt,
B. Swaminathan, and D. J. Brenner.
1995.
Bartonella (Rochalimaea) species as a cause of apparent "culture-negative" endocarditis.
Clin. Infect. Dis.
20:1044-1047[Medline].
|
| 18.
|
Spach, D. H., and J. E. Koehler.
1998.
Bartonella-associated infections.
Infect. Dis. Clin. N. Am.
12:137-155[CrossRef][Medline].
|
| 19.
|
Van Scoy, R. E.
1982.
Culture-negative endocarditis.
Mayo Clin. Proc.
57:149-154[Medline].
|
| 20.
|
Watanakunakorn, C., and T. Burkert.
1993.
Infective endocarditis at a large community teaching hospital, 1980-1990. A review of 210 episodes.
Medicine (Baltimore)
72:90-102[Medline].
|
Journal of Clinical Microbiology, September 2001, p. 3417-3419, Vol. 39, No. 9
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.9.3417-3419.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Avidor, B., Graidy, M., Efrat, G., Leibowitz, C., Shapira, G., Schattner, A., Zimhony, O., Giladi, M.
(2004). Bartonella koehlerae, a New Cat-Associated Agent of Culture-Negative Human Endocarditis. J. Clin. Microbiol.
42: 3462-3468
[Abstract]
[Full Text]